Researchers receive prestigious European Health Award for project on new psychoactive drugs

The prestigious European Health Award 2013 has been awarded to Dr Ornella Corazza for the Recreational Drugs European Network (ReDNet), a collaborative prevention project on new psychoactive drugs led by University of Hertfordshire researchers Professor Fabrizio Schifano and Dr Corazza.

Every week, a new psychoactive substance pops up on the Internet.  Just an easy 'click away' from our homes, these drugs are potentially available to everyone, and especially young people who are most at risk. With very limited knowledge about the effects and health risks of these drugs, the ReDNet project was set up to identify and research these dangerous chemicals and to provide evidence-based information to risk groups, health care providers and policy makers.

On receiving the award, ReDNet Manager Dr Ornella Corazza said: "I would like to thank the European Health Forum Gastein for this important award also on behalf of my ReDNet colleagues based in ten research centres across the European Union and research collaborators, including the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), who made this possible through hard work and effective partnership.

"So far in 2013, more than one new substance has been reported every week. It is a challenge that needs rapid and innovative responses. This European Health Award is an acknowledgement of our efforts to respond quickly and innovatively to this challenge."

The emergence of new psychoactive substances (NPSs) has led to unpredictable challenges in terms of public health in Europe. Often advertised on the Internet as legal and safer alternatives to illicit drugs, these substances appear very quickly on the drug market and may have widespread and long-term effects on users' health.

ReDNet, sponsored by the European Commission, was able to improve intelligence and generate original data on the availability and misuse of over 700 new psychoactive substances and products.  The project monitors the Internet on a daily basis in eight different languages and disseminates evidence-based information via a multitude of tools - such as mobile phone technology, virtual learning environments, video-clips, social networking and a large number of scientific publications.

Dr Corazza concluded: "ReDNet currently provides information on new psychoactive substances and services to vulnerable individuals, health and other professionals, policy makers and regulatory authorities in over 30 countries. This has increased awareness of risks, health prevention initiatives, policies and treatment provision in a rather unique way."

The innovative ReDNet project received the renowned European Health Award at the European Health Forum Gastein 2013 (EHFG 2013), beating five other cross-border initiatives that were also nominated.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder